Patent · US Active

Methods for diagnosing celiac sprue and reagents useful therein

US7923532B2 · kind B2 · utility

13Cited by

13References

5Claims

0Family size

Assignee

The Board of Trustees of the Leland Stanford Junior University · US

Inventors

Felix Hausch · Munich, DE
Gary Gray · Stanford, US
Lu Shan · Houston, US
Chaitan Khosla · Palo Alto, US

Key dates

Filing date	Oct 29, 2007
Grant date	Apr 12, 2011
Priority date	—
Expiry date	Apr 23, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.